基于对照品和对照提取物的中药复方质量控制对比研究
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

北京自然科学基金项目(7192117)


Quality Control of Chinese Medicinal Compound Based on Reference Substance and Reference Extract:A Comparative Study
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:建立以决明子中萘并吡喃酮类对照提取物和对照品为对照物质的脂康颗粒含量测定方法并对结果进行对比分析,探讨中药对照提取物替代单体对照品在中药复方质量控制中应用的适用性和可行性。方法:分别以红镰霉素-6-O-β-D-龙胆二糖苷、决明子苷B2、决明子苷C、决明子苷C2这4个对照品和已知含量的决明子对照提取物为对照,采用高效液相色谱法,测定4种成分在脂康颗粒复方中的含量,并对2种方法所得的结果进行t检验。结果:实验结果表明,4种成分的含量在对照提取物法与对照品法比较,差异有统计学意义(P>0.05)。结论:对照提取物可以作为脂康颗粒质量控制中的对照物质。为萘并吡喃酮类对照提取物用于含决明子的中药复方的质量评价提供了科学依据和研究基础,对中药对照提取物代替化学对照品进行中药复方质量控制的可行性和适用性进行了验证。

    Abstract:

    To establish a method to determine the content of Zhikang Granules with the naphthopyranone reference extract(NRE) and reference substance in Cassiae Semen and compare and analyze the results to explore the applicability and feasibility of the application of Chinese medicinal reference extract instead of monomer reference substance in the quality control of Chinese medicinal compound.Methods:Four reference substances,rubrofusarin-6-O-β-D-gentiobioside,cassiaside B2,cassiaside C,and cassiaside C2,and NRE with known content were used as the controls,and the content of the four components in Zhikang Granules was determined by HPLC.The results obtained by the two methods were analyzed by the t-test.Results:The experimental results showed that the content of the four components were significantly different between the reference extract method and the reference substance method(P>0.05).Conclusion:NRE can be used as the reference substance in the quality control of Zhikang Granules.The findings of this study are expected to provide a scientific basis for the application of NRE in the quality evaluation of Chinese medicinal compounds containing Cassiae Semen,and verify the feasibility and applicability of Chinese medicinal reference extracts instead of chemical controls used in the quality control of Chinese medicinal compounds.

    参考文献
    相似文献
    引证文献
引用本文

张颜,周德勇,王路,高艳艳,林天凤,刘斌,姜艳艳.基于对照品和对照提取物的中药复方质量控制对比研究[J].世界中医药,2022,(16).

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2021-07-10
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-09-21
  • 出版日期:
文章二维码